Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 24524596)

1.

Evidence for the presence of active paraoxonase 1 in small-dense low-density lipoprotein.

Gugliucci A, Caccavello R, Kotani K, Kimura S.

Redox Rep. 2014 Jul;19(4):154-60. doi: 10.1179/1351000214Y.0000000084. Epub 2014 Feb 14.

PMID:
24524596
2.

Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.

Gugliucci A.

Clin Chim Acta. 2014 Feb 15;429:38-45. doi: 10.1016/j.cca.2013.11.021. Epub 2013 Nov 23.

PMID:
24280342
3.

Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.

Vekic J, Kotur-Stevuljevic J, Jelic-Ivanovic Z, Spasic S, Spasojevic-Kalimanovska V, Topic A, Zeljkovic A, Stefanovic A, Zunic G.

Eur J Clin Invest. 2007 Sep;37(9):715-23.

PMID:
17696961
4.

Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis.

Olama SM, Elarman MM.

Rheumatol Int. 2013 Jun;33(6):1487-94. doi: 10.1007/s00296-012-2591-1. Epub 2012 Dec 14.

PMID:
23239038
5.

Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.

Sumegová K, Blazícek P, Waczulíková I, Zitnanová I, Duracková Z.

Acta Biochim Pol. 2006;53(4):783-7. Epub 2006 Nov 14.

6.

Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.

Miyamoto T, Takahashi Y, Oohashi T, Sato K, Oikawa S.

J Vet Med Sci. 2005 Mar;67(3):243-8.

7.

Serum paraoxonase enzyme activity and oxidative stress in obese subjects.

Aslan M, Horoz M, Sabuncu T, Celik H, Selek S.

Pol Arch Med Wewn. 2011 Jun;121(6):181-6.

8.

Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation.

Mehdi MM, Rizvi SI.

Arch Med Res. 2012 Aug;43(6):438-43. doi: 10.1016/j.arcmed.2012.08.012. Epub 2012 Sep 5.

PMID:
22959975
9.

Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.

Aslan M, Nazligul Y, Horoz M, Bolukbas C, Bolukbas FF, Gur M, Celik H, Erel O.

Atherosclerosis. 2008 Jan;196(1):270-4. Epub 2006 Nov 27.

PMID:
17125774
10.

Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes.

Tsuzura S, Ikeda Y, Suehiro T, Ota K, Osaki F, Arii K, Kumon Y, Hashimoto K.

Metabolism. 2004 Mar;53(3):297-302.

PMID:
15015140
11.

Increased oxidized-LDL levels and arylesterase activity/HDL ratio in ESRD patients treated with hemodialysis.

Mahrooz A, Zargari M, Sedighi O, Shaygani H, Gohari G.

Clin Invest Med. 2012 Jun 1;35(3):E144-51.

PMID:
22673317
12.

Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B.

Karsen H, Binici I, Sunnetcioglu M, Baran AI, Ceylan MR, Selek S, Celik H.

Afr Health Sci. 2012 Jun;12(2):114-8. doi: 10.4314/ahs.v12i2.6.

13.

Hypochlorous acid and low serum paraoxonase activity in haemodialysis patients: an in vitro study.

Sutherland WH, de Jong SA, Walker RJ.

Nephrol Dial Transplant. 2004 Jan;19(1):75-82.

14.

Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance.

Agirbasli M, Tanrikulu A, Erkus E, Azizy M, Sevim BA, Kaya Z, Taskin A, Aksoy N, Demirbag R.

Acta Cardiol. 2014 Dec;69(6):679-85.

PMID:
25643439
15.

The paraoxonase 1, 2 and 3 in humans.

Rajkovic MG, Rumora L, Barisic K.

Biochem Med (Zagreb). 2011;21(2):122-30. Review.

16.

Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.

Asefi M, Vaisi-Raygani A, Bahrehmand F, Kiani A, Rahimi Z, Nomani H, Ebrahimi A, Tavilani H, Pourmotabbed T.

Br J Dermatol. 2012 Dec;167(6):1279-86. doi: 10.1111/j.1365-2133.2012.11170.x.

PMID:
22835076
17.

Alterations of paraoxonase and platelet-activating factor acetylhydrolase activities in patients on peritoneal dialysis.

Liberopoulos EN, Papavasiliou E, Miltiadous GA, Cariolou M, Siamopoulos KC, Tselepis AD, Elisaf MS.

Perit Dial Int. 2004 Nov-Dec;24(6):580-9.

18.

Clinical study on the effect of simvastatin on paraoxonase activity.

Muacević-Katanec D, Bradamante V, Poljicanin T, Reiner Z, Babić Z, Simeon-Rudolf V, Katanec D.

Arzneimittelforschung. 2007;57(10):647-53.

PMID:
18074758
19.

Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.

Javadzadeh A, Ghorbanihaghjo A, Bahreini E, Rashtchizadeh N, Argani H, Alizadeh S.

Retina. 2012 Apr;32(4):658-66. doi: 10.1097/IAE.0b013e31822529b1.

PMID:
22030834
20.

Vitamin C attenuates hypochlorite-mediated loss of paraoxonase-1 activity from human plasma.

Kunes JP, Cordero-Koning KS, Lee LH, Lynch SM.

Nutr Res. 2009 Feb;29(2):114-22. doi: 10.1016/j.nutres.2009.01.003.

PMID:
19285602
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk